Personal Genomics
November 17, 2009 | Terry Sharrer
As genome sequencing technology becomes faster and cheaper, researchers such as Elaine Mardis, at Washington University School of Medicine (St. Louis) can begin to figure out the DNA that distinguish normal tissue, from that of a primary tumor, from that of a primary tumor’s metastatic cast offs. Her lab is now capable of sequencing about 50 genomes per year, but expects that to rise sharply. MORE
Image Credit: Technology Review
The Grenome sequencing Center Washington University School of Medicine (St. Louis)